PD-1 is still in the clinical research stage. You need to go to a major cancer research center that has trials going on and see if you qualify.
The NIH has a website that lists all the clinical trials – but for a novice it is hard to understand what they are talking about. If I were you, I would ask my doctor what major research center he/she would want me to go to, and I would ask the office to call and make the appointment for me. You get in faster that way.
Also, be prepared to have all your scans and boipsies physically sent to the research center. They want their own people to look at the actual tests, not just the report. You want this also, because these researchers are the best there are.
PD-1 is still in the clinical research stage. You need to go to a major cancer research center that has trials going on and see if you qualify.
The NIH has a website that lists all the clinical trials – but for a novice it is hard to understand what they are talking about. If I were you, I would ask my doctor what major research center he/she would want me to go to, and I would ask the office to call and make the appointment for me. You get in faster that way.
Also, be prepared to have all your scans and boipsies physically sent to the research center. They want their own people to look at the actual tests, not just the report. You want this also, because these researchers are the best there are.
PD-1 is still in the clinical research stage. You need to go to a major cancer research center that has trials going on and see if you qualify.
The NIH has a website that lists all the clinical trials – but for a novice it is hard to understand what they are talking about. If I were you, I would ask my doctor what major research center he/she would want me to go to, and I would ask the office to call and make the appointment for me. You get in faster that way.
Also, be prepared to have all your scans and boipsies physically sent to the research center. They want their own people to look at the actual tests, not just the report. You want this also, because these researchers are the best there are.
The latest statistics for Merck's anti-PD1 drug (MK-3475) are much better than anything else I have seen for the treatment of melanoma… 41% response rate with 81% survival at 1 year. While still in the clinical trial stage, it is supposed to be approved by the FDA later this year.
The next best thing out there is Yervoy (ipilimumab)… not sure what the response rate was but 1-year survival from the trial stage was 46% and 2-year was 24%.
The latest statistics for Merck's anti-PD1 drug (MK-3475) are much better than anything else I have seen for the treatment of melanoma… 41% response rate with 81% survival at 1 year. While still in the clinical trial stage, it is supposed to be approved by the FDA later this year.
The next best thing out there is Yervoy (ipilimumab)… not sure what the response rate was but 1-year survival from the trial stage was 46% and 2-year was 24%.
The latest statistics for Merck's anti-PD1 drug (MK-3475) are much better than anything else I have seen for the treatment of melanoma… 41% response rate with 81% survival at 1 year. While still in the clinical trial stage, it is supposed to be approved by the FDA later this year.
The next best thing out there is Yervoy (ipilimumab)… not sure what the response rate was but 1-year survival from the trial stage was 46% and 2-year was 24%.
Kevin
Viewing 5 reply threads
You must be logged in to reply to this topic.
About the MRF Patient Forum
The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.
The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.
.
.
